The price of Medical Properties Trust Inc. (NYSE: MPW) closed at $6.09 in the last session, down -4.25% from day before closing price of $6.36. In other words, the price has decreased by -$0.27 from its previous closing price. On the day, 13625248 shares were traded. MPW stock price reached its highest trading level at $6.31 during the session, while it also had its lowest trading level at $6.09.
We take a closer look at MPW’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.23 whereas as Long-Term Debt/Eq ratio is at 1.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on August 31, 2023, Downgraded its rating to Neutral and sets its target price to $9 from $18 previously.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MPW now has a Market Capitalization of 3.64B and an Enterprise Value of 13.72B. As of this moment, Medical’s Price-to-Earnings (P/E) ratio for their current fiscal year is 52.05, and their Forward P/E ratio for the next fiscal year is 7.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.65 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at 9.66 whereas that against EBITDA is 20.98.
Stock Price History:
Over the past 52 weeks, MPW has reached a high of $14.00, while it has fallen to a 52-week low of $6.24. The 50-Day Moving Average of the stock is 8.37, while the 200-Day Moving Average is calculated to be 9.62.
According to the various share statistics, MPW traded on average about 11.49M shares per day over the past 3-months and 11.71M shares per day over the past 10 days. A total of 598.34M shares are outstanding, with a floating share count of 590.74M. Insiders hold about 1.20% of the company’s shares, while institutions hold 84.10% stake in the company. Shares short for MPW as of Aug 30, 2023 were 128.61M with a Short Ratio of 128.61M, compared to 123.96M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 21.49% and a Short% of Float of 29.94%.
Dividends & Splits
The forward annual dividend rate for MPW is 0.60, which was 1.16 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 18.24%, it implies a Forward Annual Dividend Yield of 16.04%. The stock’s 5-year Average Dividend Yield is 6.81.
The company has 7 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0.19 for the current quarter, with a high estimate of $0.2 and a low estimate of $0.17, while EPS last year was $0.37. The consensus estimate for the next quarter is $0.18, with high estimates of $0.2 and low estimates of $0.17.
Analysts are recommending an EPS of between $0.38 and $0.33 for the fiscal current year, implying an average EPS of $0.36. EPS for the following year is $0.85, with 8 analysts recommending between $0.92 and $0.79.
According to 7 analysts, the current quarter’s revenue is expected to be $341.83M. It ranges from a high estimate of $358.3M to a low estimate of $328M. As of the current estimate, Medical Properties Trust Inc.’s year-ago sales were $352.34M, an estimated decrease of -3.00% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $337.42M, a decrease of -11.30% less than the figure of -$3.00% in the same quarter last year. There is a high estimate of $360.8M for the next quarter, whereas the lowest estimate is $311.43M.
A total of 8 analysts have provided revenue estimates for MPW’s current fiscal year. The highest revenue estimate was $1.41B, while the lowest revenue estimate was $1.34B, resulting in an average revenue estimate of $1.38B. In the same quarter a year ago, actual revenue was $1.54B, down -10.80% from the average estimate. Based on 9 analysts’ estimates, the company’s revenue will be $1.4B in the next fiscal year. The high estimate is $1.5B and the low estimate is $1.32B. The average revenue growth estimate for next year is up 2.10% from the average revenue estimate for this year.